Design, Synthesis, and Biological Evaluation of N-Acyl-Hydrazone-Linked Quinazolinone Derivatives with Antioxidant, Antimicrobial, and Anticancer Potential
<b>Objectives</b>: Combining two pharmacophores into one molecule with multiple applications presents interest in the field of medicinal chemistry. Quinazolinones are among privileged scaffolds due to their wide biological activities, whereas hydrazones are versatile linkers with pharmacological potential. Thus, this article focused on a green method for the synthesis of new <i>N</i>-acyl-hydrazones of 2-(2-methyl-4-oxoquinazolin-3(4<i>H</i>)-yl)acetohydrazide and the exploration of their biological potential. <b>Methods</b>: The novel <i>N</i>-acyl-hydrazones (<b>1a</b>-<b>1f</b>) were synthesized under microwave irradiation, using various substituted salicylaldehydes and benzaldehydes. The products were characterized by FT-IR, <sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS. Their pharmacological profile was assessed by in silico methods and docking simulations. Biological evaluation included antioxidant, antimicrobial, and cytotoxic activities, as well as preliminary toxicity on <i>Artemia franciscana</i>. <b>Results</b>: Spectroscopic data indicated <i>syn-E</i> and <i>anti-E</i> isomers. Compound <b>1c</b> showed the highest antioxidant activity. Antimicrobial assays indicated narrow-spectrum activity, with compounds <b>1a</b> and <b>1b</b> being most effective against <i>C. albicans</i> and <i>S. aureus</i>. Biofilm inhibition assays revealed that <b>1a</b> and <b>1c</b> interfered with microbial adhesion, highlighting their potential in combating biofilm-associated infections. Cytotoxicity tests on HT-29 and A431 cancer cell lines showed selective anticancer effects for compounds <b>1a</b>-<b>1d</b>, with minimal toxicity on normal Vero cells, especially for <b>1b</b> and <b>1d</b>. Toxicity against <i>Artemia franciscana</i> correlated with in vitro cytotoxicity data, revealing low lethality for all <i>N</i>-acyl-hydrazones. Docking studies indicate that the antibacterial activity may involve inhibition of <i>S. aureus</i> DNA gyrase B, whereas the cytotoxic effects could be mediated by interaction with the EGFR kinase. <b>Conclusions</b>: These findings may increase the chances of identifying a lead compound in this class, supporting the further development of selected <i>N</i>-acyl-hydrazones and their pharmacological exploration.
Authors
- Maria Coandă (ORCID: https://orcid.org/0009-0006-8136-2629)
- Bianca Gălățeanu (ORCID: https://orcid.org/0000-0001-8093-1750)
- Diana Camelia Nuță (ORCID: https://orcid.org/0000-0002-7685-3291)
- Ariana Hudiță (ORCID: https://orcid.org/0000-0002-9439-9432)
- Lucia Pintilie (ORCID: https://orcid.org/0000-0002-1036-7653)
- Irina Zarafu (ORCID: https://orcid.org/0000-0002-9144-5528)
- Carmen Limban (ORCID: https://orcid.org/0000-0001-6212-594X)
- Petre Ioniță
- Cornel Chiriță
- Constantin Drăghici
- Ioana-Cristina Marinaș
- Erzsébet-Eleonóra Kapronczai (ORCID: https://orcid.org/0000-0002-4912-0586)
- Denisa-Ioana Crăciun
- Robert-Viorel Ancuceanu
Institutions
- University of Bucharest (RO)
- Carol Davila University of Medicine and Pharmacy (RO)
- Babeș-Bolyai University (RO)
- National Institute of Research and Development for Biological Sciences (RO)
- National Institute For Chemical Pharmaceutical Research and Development (RO)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2025-12-26
- DOI
- https://doi.org/10.3390/ph19010057
- Primary Topic
- Quinazolinone synthesis and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00